CACNA2D1 and epilepsy: There is also support for CACNA2D1 in other psychiatric disorders that are correlated with SCZ, e.g., epilepsy and intellectual disability [40], and CACNA2D1 has been identified as a potential drug target in MDD from GWAS [41].